Publications: Kerfoot, Maria

Journal Article

Fletcher, S., Hall, C., Anastasas, M., Martin, A., Chai, T., Priebatsch, K., Stirnweiss, A., Francis, R.W., Juraja, S.M., Mills, A.D., Ong, F., Florez, L., Kerfoot, M., Nicholls, J., Champain, D. and Cunningham, P. (2021) RNA therapeutics in the treatment of retinal disease - delivering the potential. Investigative Ophthalmology and Visual Science, 62 (8). Art. 1196.

Hoffmann, K., Milech, N., Juraja, S.M., Cunningham, P.T., Stone, S.R., Francis, R.W., Anastasas, M., Hall, C.M., Heinrich, T., Bogdawa, H.M., Winslow, S., Scobie, M.N., Dewhurst, R.E., Florez, L., Ong, F., Kerfoot, M., Champain, D., Adams, A.M., Fletcher, S., Viola, H.M., Hool, L.C., Connor, T., Longville, B.A.C., Tan, Y-F, Kroeger, K., Morath, V., Weiss, GA., Skerra, A., Hopkins, R.M. and Watt, P.M. (2018) A platform for discovery of functional cell-penetrating peptides for efficient multi-cargo intracellular delivery. Scientific Reports, 8 (1).

Keenan, M., Alexander, P.W., Diao, H., Best, W.M., Khong, A., Kerfoot, M., Thompson, R.C.A., White, K.L., Shackleford, D.M., Ryan, E., Gregg, A.D., Charman, S.A., von Geldern, T.W., Scandale, I. and Chatelain, E. (2013) Design, structure–activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi. Bioorganic & Medicinal Chemistry Letters, 21 (7). pp. 1756-1763.

Keenan, M., Abbott, M.J., Alexander, P.W., Armstrong, T., Best, W.M., Berven, B.M., Botero Gomez, A., Chaplin, J.H., Charman, S.A., Chatelain, E., von Geldern, T.W., Kerfoot, M., Khong, A., Nguyen, T., McManus, J.D., Morizzi, J., Ryan, E., Scandale, I., Thompson, R.A., Wang, S.Z. and White, K.L. (2012) Analogues of Fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas Disease. Journal of Medicinal Chemistry, 55 (9). pp. 4189-4204.